1-2 of 2
Pavel Zak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FLT3-ITD measurable residual disease from the QuANTUM-First trial

Open Access
Clinical Trials & Observations
Mark J. Levis, Harry P. Erba, Pau Montesinos, Hee-Je Kim, Radovan Vrhovac, Elzbieta Patkowska, Pavel Zak, Po-Nan Wang, Jaime E. Connolly Rohrbach, PhD, Ken Chang, Li Liu, Yasser Mostafa Kamel, Karima Imadalou, Arnaud Lesegretain, Jorge E. Cortes, Mikkael A Sekeres, Hervé Dombret, Sergio Amadori, Jianxiang Wang, Richard F. Schlenk, Alexander E. Perl
Journal: Blood Advances
Blood Adv bloodadvances.2025016444.
https://doi.org/10.1182/bloodadvances.2025016444
Published: 2025
Includes: Supplemental data
Journal Articles

Blinatumomab consolidation and maintenance therapy in adults with relapsed/refractory B-precursor acute lymphoblastic leukemia

Free
Clinical Trials & Observations
Alessandro Rambaldi, Francoise Huguet, Pavel Zak, Paul Cannell, Qui Tran, Janet Franklin, Max S. Topp
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1518–1525.
https://doi.org/10.1182/bloodadvances.2019000874
Published: 2020
Includes: Supplemental data